RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - IL RECETTORE A3 DELL'ADENOSINA COME BERSAGLIO FARMACOLOGICO E "BIOMARKER" PER LA TUMORIGENESI NELL'UOMO
• 2 - Avanzamenti nella diagnosi molecolare e nel trattamento dei tumori neuroendocrini
• 3 - Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale
• 4 - Ruolo dell'ATP extracellulare nella patogenesi delle neoplasie tiroidee e nella modulazione di vecchi e nuovi markers di malattia
• 5 - Agenti infettivi e fattori alimentari nell'oncogenesi della vescica del bovino: meccanismi patogenetici e sicurezza alimentare.
• 6 - Progressione dei carcinomi della ghiandola mammaria e della prostata: nuovi meccanismi ormonali e approcci terapeutici.
• 7 - Targeting molecolare e sviluppo di un nuovo approccio alla terapia radiorecettoriale del carcinoma tiroideo di derivazione dall'epitelio follicolare non iodocaptante.
• 8 - Tumori Neuroendocrini Polmonari (Carcinoidi) e Gastro-Entero-Pancreatici (GEP): Caratterizzazione clinica, immunofenotipica e molecolare nella definizione della prognosi e dell'iter terapeutico.
• 9 - Sviluppo e progressione del carcinoma epatocellulare: meccanismi molecolari ed implicazioni terapeutiche
• 10 - Meccanismi molecolari di carcinogenesi: validazione di nuovi bersagli per la diagnosi e la terapia

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze agrarie e veterinarie
  • PATOLOGIA GENERALE E ANATOMIA PATOLOGICA VETERINARIA
  • CLINICA MEDICA VETERINARIA
  • CLINICA CHIRURGICA VETERINARIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
• HUMAN NECESSITIES
  • AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

Classificazione geografica

• Regione: Umbria

Bibliografia

ABRAMOVICH CM, PRAYSON RA: Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 1999; 123: 793.
AGUIAR PH, TSANACLIS AM, TELLA OI, PLESE JP: Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics. Neurosurg Rev 2003; 26: 221-228.
AHMED A, TOLLEFSBOL T: Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer. J Am Geriatr Soc 2003; 51: 116-122.
ARGYLE DJ, NASIR L: Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Vet Pathol 2003: 40:1-7.
BLACKBURN EH: Structure and function of telomeres. Nature 1991;350: 569-573.
BOLDRINI L, PISTOLESI S, GISFREDI S, URSINO S: Telomerase in intracranial meningiomas. Int J Mol Med 2003;12: 943-947.
BRANDIS A, MIRZAI S, TATAGIBA M et al.: Immunoistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33. 212-218,1993
CABUY E, DE RIDDER L: Telomerase activity and expression of telomerase riverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Arch 2001;439:176.
CAHILL DW, BASHIRELAHI N, SOLOMON LW, DALTON T, SALCMAN M and DUCKER T: Estrogen and progesterone receptors in meningiomas. J Neurosurg 60: 985-993,1984
CUSHING H, EISENHARDT L: Meningiomas: Their Classification, Regional Behavior, Life History and Surgical End Results. Springfield, III: Charles C Thomas,1938,785
DAS A, TAN WL, SMITH DR: Expression of extracellular matrix markers in benign meningiomas. Neuropathology 23:275-281,2004
DONNELL MS, MEYER GA, DONEGAN WL: Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50:499-502,1979
EARLE KM, RICHANY SF: Meningiomas. A study of the histology, incidence and biologic behavior of 243 cases from the Frazier-Grant collection of brain tumors. Med Ann DC 38:353-358,1969
EVANS SM, DAYRELL-HART B et al. Radiation Therapy of Canine Brain Masses. J Vet Int Med 7:216-219,1993
FALCHETTI ML, LAROCCA LM, PALLINI R : Telomerase in brain tumors. Childs Nerv Syst 2002;18:112-117.
GALLAGHER JG, BERG J, KNOWLWS KE, WILLIAMS LL, BRONSON RT. Prognosis after surgical exicion of cerebral meningiomas in cats: 17 cases (1986-19929. JAVMA 203:1437-1440, 1993
GORDON LE, THACHER C, MATTHIESEN DT, JOSEPH RJ: Results of craniotomy for the treatment of cerebral meningioma in 42 cats. Vet Surg 1994; 23: 94-100.
GRUNBERG SM, WEISS MH, SPITZ IM, SANDUN A, RUSSEL CA, LUCCI L, STEVENSON LL: Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurgery 74:861-866, 1991
HEIDNER GL, KORNEGAY JN, PAGE RL, DODGE RK, THRALL DE: Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Int Med 1991; 5: 219-226.
HO DM, HSU CY, TING LT, CHIAND H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer 2002; 94:1538.
KAYASELCUK F, ZORLUDEMIR S, GUMURDUHU D, ZEREN H, ERMAN T: PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neurooncol 2002; 57: 115-121.
KLEINER DE, STETLER-STEVENSON WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43:S42-S51, 1999
LANA SE, OGILVIE GK, HANSEN RA: Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res 61:111-114, 2000
LEIBMAN NF, LANA SE, HANSEN RA: Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J Vet Intern Med 14:583-586, 2000
LOUKOPOULOS P, MUNGALL BA, STRAW RC, RHORNTON JR, ROBINSON WF: Matrix Metalloproteinase-2 and -9 Involvement in Canine Tumors. Vet Pathol 40:382-394 (2003)
LUGINBUHL H, FRANKHAUSER R, McGRATH JT: Spontaneous neoplasms of the Central System in Animal. Prog Neurol Surg 2: 1968
MAELEY J Jr, CARTER JE: Spinal cord tumor during pregnancy. Obstet Gynecol 32:204-209, 1968
MAES L, LIPPENS E, KALALA JPO, DE RIDDER L: The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. Cell Prolif 2005;38:3-12.
MANDARA MT, RICCI G, RINALDI L, SARLI G, VITELLOZZI G: Immunohistochemical Identification and Image Analysis Quantification of Oestrogen and Progesterone Receptors in Canine and Feline Meningioma. J Comp Path 127:214-218, 2002
MAGDELENAT H, PERTUISET BF, POISSON M et al: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir. 64:199-213, 1982
MARTUZA RL, MacLAUGHLIN DT, OJEMAN RG: Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurg 9: 665-671, 1981
McCUTCHEON IE: The biology of meningiomas. Journal of Neuro-Oncology 29:207-216, 1996
MORESCO RM, SCHEITHAUER BW, LUCIGNANI G, LOMBARDI D, ROCCA A, LOSA M, CASATI R, GIOVANELLI M and FAZIO F: Oestrogen receptors in meningiomas: A correlative PET and immunohistochemical study. Nuclear Medicine Communication 18.606-615, 1997
MOSES MA, WIEDERSCHAIN D, LOUGHLIN KR: Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58:1395-1399, 1998
NASIR L, DEVLIN P, McKEVITT T, RUTTEMAN G, ARGYLE DJ: Telomere lengths and telomerase activity in dog tissues. Neoplasia 2001; 3: 351-359.
NIEBAUER GW, DAYRELL-HART BL: Evaluation of craniotomy in dogs and cats. J Am Vet Med Ass 198:89-95, 1991
OKADA M, MIYAKE K, MATSUMOTO Y, KAWAI N, KUNISHIO K, NAGAO S: Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. Neurooncol 66:29-37, 2004
PAEK SH, KIM CY, KIM YY, PARK IA, KIM MS, KIM DG, JUNG HW: Correlation of clinical and biological parameters with peritumoral edema in meningioma. Neurooncol 60:235-45, 2002
POISSON M, MAGDELENAT H, FONCIN JF et al. Recepturs d’oestrogenes et de progesterone dans le meningiomes. Etude de 22 cas. Rev Neurol 136: 193-203
RISHING EJ, COLVIN SM, GAZDAR A, MIURA N, WHITE III CL; Coimbra C, Burns DK: Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas. J Neuro-Oncol 1999;45:199-207
RUSSEL DS, RUBINSTEIN LJ: Pathology of Tumors of the Nervous System. Baltimore: Williams & Wilkins, 1977, 65-100
SCHNEGG JF, GOMEZ F, LEMARCHAND-BERAUD T et al. Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 15: 415-418, 1981
SHOENBERG BS, CHRISTINE BW, WHISNANT JP: Nervous System neoplasm and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25:705-712,1975
SIMON M, PARK TW, KOSTER G, MAHLBERG R, HACKENBROCH M, BOSTROM J, LONING T, SCHRAMM J: Alterations of INK4ap16-p14ARF/INK4bp15 expression and telomerase activation in meningioma progression. J Neuro-Oncol 2001;55:149-158.
SPECIALE J, KOFFMAN BM, BASHIRELAHI N, STEINBER SA: Identification of gonadal steroid receptors in meningiomas from dogs and cats. Am J Vet Res 61:833-835, 1990
TALVENSAARI-MATTILA A, PAAKKO P, HOYHTYA M: Matrix metalloproteinase-2 immunoreactive protein. A marker of aggressive in breast carcinoma. Cancer 83:1153-1162,1998
THEON AP, LECOUTER RA, CARR EA, GRIFFEY SM: Influence of tumor cell proliferation and sex-hormone receptors on effectiveness of radiation therapy for dogs with incompletely resected meningiomas. JAVMA 216:701-707,2000
TONN JC, OTT MM, BOUTERFA H et al. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Neurosurg 41: 1152-1159,1997
YAZAWA M, OKUDA M, SETOGUCHI A, NISHAMURA R, SASAKI N, HASEGAWA A, TOSHIHIRO W, TSUJIMOTO H: Measurement of telomerase activity in dog tumours. J Vet Int Med Sci 1999;61:1125-1129.
ZAKIAN VA: Structure and function of telomeres. Annu Rev Genet 1989; 579-604.

Parole Chiave

MENINGIOMA; RECETTORI PER IL PROGESTERONE; METALLOPROTEINASI; TELOMERASI; ATTIVITÀ PROLIFERATIVA CELLULARE; IMMUNOISTOCHIMICA; TUMORI; SISTEMA NERVOSO; FATTORI PROGNOSTICI